Astra Zeneca is a global, innovation-driven, integrated biopharmaceutical company.
Our mission is to make a meaningful difference to patient health through great medicines that bring benefit for patients and add value for our stakeholders and society. We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Read more about our medicines.
We also work with others to combine complementary skills and strengthen the platform for success in meeting a common goal: improved healthcare. Find out more about partnering with us. We are active in over 100 countries with a growing presence in emerging markets including China, Brazil, India and Russia. We employ over 62,000 people (47% in Europe, 31% in the Americas and 22% in Asia, Africa and Australasia). Read more about our employees and our culture. We invest over $4 billion in R&D each year and have over 11,000 people in our R&D organisation. Read more about our research.
In 2009, our worldwide sales totalled $32.8 billion (including 10 medicines with sales of over $1 billion each). View details of our financial performance. Alongside our commitment to competitiveness and performance, we continue to be led by our core values to achieve sustainable success. We are positioned in the top 6% in the sector in the Dow Jones World and STOXX (European) Sustainability Indexes. Find out more about our commitment to responsibility.
As a global biopharmaceutical company, our activities touch many people’s lives.For patients and physicians, we provide medicines for some of the world’s most serious diseases. For the people who pay for healthcare, we work to make sure that our medicines offer real value for money. For our employees, we provide a culture in which they can feel appreciated, energised and rewarded for their contribution. For our shareholders, we aim to deliver value through our continued focus on innovation and running our business efficiently. For the wider community, we want to be valued for the contribution our medicines can make to society and trusted for the way in which we do business. We work closely with all these groups to gain the insights we need to maintain a flow of life-changing medicines that make a real difference for patients in the fight against disease and which add value for our stakeholders and society.
We have a highly experienced Board and Senior Executive Team. The Board sets the Company’s strategy and policies, and monitors progress towards meeting our objectives. This includes regular reviews of financial performance and critical business issues. The Senior Executive Team, led by Chief Executive Officer David Brennan, focuses on the day-to-day running of our business operations and our Company development, regularly reviewing and deciding all major business issues.
Office in UK:
15 Stanhope Gate
W1K 1LN London
+44 (0)20 7304 5000
+44 (0)20 7304 5151
Адрес: 119021, Москва,
Улица Тимура Фрунзе, дом 11, корпус 2-5
119334 Москва, ул. Вавилова д.24, корп. 1, Бизнес Центр "Вавилов Тауэр"
+7 495 799 56 99
+7 495 792 56 54